Phreesia is expanding Parkinson’s disease awareness through a new collaboration with The Michael J. Fox Foundation (MJFF). Phreesia leads the patient intake, outreach and activation space. Its platform supports one in six patient visits across the U.S. The company will work with MJFF to increase educational awareness across the Parkinson’s disease community. The initiative will also create stronger research onramps for eligible patients and caregivers.
MJFF remains the largest nonprofit funder of Parkinson’s research. Through this collaboration, both organizations will connect patients with useful educational resources. The six-month project will deliver timely information before medical appointments. The content will focus on Parkinson’s disease and related research opportunities.
Phreesia will reach patients and caregivers with relevant educational messaging. The information will support more informed discussions with healthcare providers. The joint campaign will launch in November. It will reach more than 100,000 clinically relevant patients and caregivers. The initiative also supports broader efforts to increase Parkinson’s disease research awareness. In addition, it will encourage eligible individuals to explore study enrollment opportunities.
Patient Education Supports Parkinson’s Research
The collaboration will use Phreesia’s digital patient engagement capabilities. These tools will help deliver MJFF resources at appropriate points in the patient journey. The campaign will serve people living with Parkinson’s disease. It will also support their caregivers with accessible educational information. Additionally, the initiative will reach people diagnosed with REM sleep behavior disorder. The condition has a close connection with Parkinson’s disease.
The campaign will also examine the value of point-of-care education. This approach may help people recognize potential neurological health concerns earlier. As part of that effort, adults aged 40 and older will receive neurological health resources. The information will encourage greater awareness around brain health. Patients will receive appointment-friendly resources from MJFF. They will also gain access to ongoing information and support.
The campaign aims to help patients ask more informed questions. It will also encourage people to recognize potential early signs. Furthermore, the initiative seeks to support more active participation in personal care. Better access to information can strengthen conversations between patients and healthcare providers. The program therefore connects patient education with broader Parkinson’s research awareness. It also creates another pathway for individuals interested in research participation.
“The Michael J. Fox Foundation’s single, urgent goal remains to find better therapies and a cure for people and families with Parkinson’s. Expanding access to trusted educational information, including how to play a role in research, is a critical part of the puzzle,” said Maggie Kuhl, Vice President of Patient Engagement at The Michael J. Fox Foundation for Parkinson’s Research. “We look forward to working with Phreesia’s digital patient engagement tools to help empower people and families to learn more about better brain health and be part of the solutions we seek.”
MJFF and Phreesia Strengthen Patient Engagement
The statement highlights the importance of trusted health information. It also emphasizes the need for stronger connections between education and research. Through the partnership, MJFF will bring its expertise to the Phreesia network. Patients can therefore access resources within the healthcare journey. The initiative combines patient engagement with Parkinson’s disease awareness. It also supports greater understanding of research opportunities.
David Linetsky, President, Phreesia Network Solutions, emphasized the value of the collaboration.
“The Michael J. Fox Foundation is a tremendous advocate and resource for families facing Parkinson’s disease, and we are delighted to bring their expertise to the Phreesia network,” said David Linetsky, President, Phreesia Network Solutions. “Supporting educational awareness and research onramps for such a serious condition is something we wholeheartedly support. Helping patients recognize symptoms of Parkinson’s earlier and get connected to the care they need is part of our ongoing effort to make care easier.”
The partnership demonstrates the growing role of digital patient engagement in healthcare. It also shows how technology can support patient education and research awareness. For Parkinson’s disease patients and caregivers, timely information can improve healthcare conversations. Meanwhile, research awareness can help eligible individuals understand potential participation opportunities.
Overall, the six-month campaign will strengthen Parkinson’s disease awareness across targeted patient groups. It will also connect educational resources with broader efforts in Parkinson’s research. The initiative begins in November and will reach more than 100,000 clinically relevant patients and caregivers. Through this effort, Phreesia and MJFF will continue supporting patient education, neurological health awareness, and research engagement.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
